Stay updated on Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.
Latest updates to the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check24 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check53 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check60 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference1%
- Check75 days agoChange DetectedSeveral links to clinical trial resources and publications have been removed, including those related to stomach and esophageal cancer, as well as various databases and documentation sites.SummaryDifference2%
Stay in the know with updates to Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.